ALHC (Alignment Healthcare, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ALHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Dawn Christine Maroney | President | Sell | — | — |
| 2026-09-11 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-08-18 | Dawn Christine Maroney | President | Sell | — | — |
| 2026-08-10 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-07-16 | Dawn Christine Maroney | President | MIXED | — | — |
| 2026-07-14 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-07-02 | Shane J. Hochradel | Chief Operations Officer | A | — | — |
| 2026-07-01 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Sell | — | — |
| 2026-06-26 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Sell | — | — |
| 2026-06-18 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Sell | — | — |
| 2026-06-15 | Dawn Christine Maroney | President | Sell | — | — |
| 2026-06-15 | Hyong Kim | Chief Medical Officer | Sell | — | — |
| 2026-06-12 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | Sell | — | — |
| 2026-06-12 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-06-09 | JOSEPH S KONOWIECKI | EVP, Corporate Affairs | A | — | — |
| 2026-06-09 | Mark D. Kent | President - MSO | A | — | — |
| 2026-06-02 | Mark D. Kent | President - MSO | Buy | — | — |
| 2026-05-19 | Dawn Christine Maroney | President | MIXED | — | — |
| 2026-05-13 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-04-15 | Dawn Christine Maroney | President | Sell | — | — |
| 2026-04-13 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-04-08 | James M Head | Chief Financial Officer | Sell | — | — |
| 2026-04-08 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-04-01 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | Sell | — | — |
| 2026-03-23 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-03-19 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | Sell | — | — |
| 2026-03-19 | Dawn Christine Maroney | President | Sell | — | — |
| 2026-03-19 | Sebastian Burzacchi | COO - Mgmt Services Org | Sell | — | — |
| 2026-03-19 | Andreas P. Wagner | Chief Human Resources Officer | Sell | — | — |
| 2026-03-19 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| 2026-03-19 | Hyong Kim | Chief Medical Officer | Sell | — | — |
| 2026-03-19 | Robert L. Scavo | Chief Information Officer | Sell | — | — |
| 2026-03-17 | Sebastian Burzacchi | COO - Mgmt Services Org | A | — | — |
| 2026-03-17 | JOSEPH S KONOWIECKI | Director | A | — | — |
| 2026-03-17 | Andreas P. Wagner | Chief Human Resources Officer | A | — | — |
| 2026-03-17 | JODY L BILNEY | Director | A | — | — |
| 2026-03-17 | JACQUELINE B KOSECOFF | Director | A | — | — |
| 2026-03-17 | Adnan R. Mansour | Chief Digital Officer | A | — | — |
| 2026-03-17 | Margaret M McCarthy | Director | A | — | — |
| 2026-03-17 | DAVID C HODGSON | Director | A | — | — |
| 2026-03-17 | Hyong Kim | Chief Medical Officer | A | — | — |
| 2026-03-17 | CHRISTOPHER J JOYCE | Chief Legal and Admin. Officer | A | — | — |
| 2026-03-17 | YON JORDEN | Director | A | — | — |
| 2026-03-17 | JOHN E KAO | Chief Executive Officer | A | — | — |
| 2026-03-17 | Dawn Christine Maroney | President | MIXED | — | — |
| 2026-03-17 | Nicholas Robbert Vorhoff | Director | A | — | — |
| 2026-03-17 | James M Head | Chief Financial Officer | A | — | — |
| 2026-03-17 | Mark B. McClellan | Director | A | — | — |
| 2026-03-13 | Robert L. Scavo | Chief Information Officer | Sell | — | — |
| 2026-03-13 | JOHN E KAO | Chief Executive Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 67,949,317 | — |
| — | Director | 61,302,175 | — |
| — | Director | 60,993,323 | — |
| — | Director | 30,842,175 | — |
| — | Director | 25,519,345 | — |
| — | Director | 24,596,079 | — |
| — | Director | 20,648,785 | — |
| — | Director | 20,648,785 | — |
| — | Director | 19,966,785 | — |
| — | Director | 17,922,779 | — |
| — | Director | 17,922,779 | — |
| — | Director | 13,476,585 | — |
| — | Director | 13,476,585 | — |
| — | Chief Executive Officer | 1,841,639 | — |
| — | Chief Clinical Officer | 1,826,538 | — |
| — | Chief Financial Officer | 1,557,348 | — |
| — | Chief Legal Officer | 1,132,692 | — |
| — | EVP, Corporate Affairs | 1,103,816 | — |
| — | Chief Med & Operating Officer | 1,088,651 | — |
| — | President | 794,606 | — |
| — | Chief Experience Officer | 678,987 | — |
| — | Director | 517,984 | — |
| — | Chief Information Officer | 487,685 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ALHC quote page; the site-wide leaderboard is on the insider transactions hub.